Marimed (MRMD) Retained Earnings (2011 - 2026)
Marimed (MRMD) posted quarterly Retained Earnings of $179.7 million for Q1 2026, up 0.87% year-over-year from $178.2 million in Q1 2025, and up 240.48% quarter-over-quarter from -$127.9 million in Q4 2025.
Marimed (MRMD) Retained Earnings (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Retained Earnings for 16 consecutive years, with $179.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 0.87% year-over-year to $179.7 million; the TTM figure through Mar 2026 stood at $179.7 million (up 0.87% YoY), while the FY2025 annual figure was -$127.9 million, down 173.79% from the prior year.
- Retained Earnings rose to $179.7 million in Q1 2026 per MRMD's latest filing, from -$127.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $179.7 million in Q1 2026 and bottomed at -$127.9 million in Q4 2025.
- Historically, Retained Earnings has averaged $8.8 million across 5 years, with a median of -$88.7 million in 2022.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 283.46% — and 2025, when it tumbled 173.79%.
- Marimed's Retained Earnings stood at $142.4 million in 2022, then tumbled by 170.21% to -$100.0 million in 2023, then jumped by 273.44% to $173.4 million in 2024, then slumped by 173.79% to -$127.9 million in 2025, then soared by 240.48% to $179.7 million in 2026.
- Business Quant data shows MRMD's Retained Earnings at $179.7 million in Q1 2026, -$127.9 million in Q4 2025, and $179.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 3.75 Bn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 180.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 180.05 Mn |
| Mar 31, 2026 | 179.72 Mn |
| Dec 31, 2025 | -127.93 Mn |
| Sep 30, 2025 | 179.06 Mn |
| Jun 30, 2025 | -118.84 Mn |
| Mar 31, 2025 | 178.17 Mn |
| Dec 31, 2024 | 173.37 Mn |
| Sep 30, 2024 | -103.92 Mn |
| Jun 30, 2024 | -102.90 Mn |
| Mar 31, 2024 | -101.25 Mn |
| Dec 31, 2023 | -99.96 Mn |
| Sep 30, 2023 | -89.79 Mn |
| Jun 30, 2023 | 167.65 Mn |
| Mar 31, 2023 | -84.57 Mn |
| Dec 31, 2022 | 142.37 Mn |
| Sep 30, 2022 | -88.68 Mn |
| Jun 30, 2022 | -91.38 Mn |
| Mar 31, 2022 | 138.06 Mn |
| Dec 31, 2021 | -97.39 Mn |
| Sep 30, 2021 | 127.23 Mn |